[{"address1": "171 Oyster Point Boulevard", "address2": "Suite 500", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 825 6990", "website": "https://www.tenayatherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company's lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. The company develops its products through gene editing, cellular regeneration, gene silencing, and gene addition. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 97, "companyOfficers": [{"maxAge": 1, "name": "Mr. Faraz  Ali M.B.A.", "age": 51, "title": "CEO, Interim Principal Financial Officer & Director", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 790275, "exercisedValue": 0, "unexercisedValue": 327250}, {"maxAge": 1, "name": "Dr. Deepak  Srivastava M.D.", "age": 57, "title": "Scientific Founder, Chairman of Scientific Advisory Board & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 128000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Whittemore G. Tingley M.D., PH.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 606555, "exercisedValue": 0, "unexercisedValue": 48750}, {"maxAge": 1, "name": "Dr. Eric N. Olson Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bruce R. Conklin M.D.", "title": "Scientific Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Saptarsi  Haldar M.D.", "title": "Scientific Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sheng  Ding Ph.D.", "title": "Scientific Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Benoit G. Bruneau Ph.D.", "title": "Scientific Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomohiro  Higa M.B.A.", "age": 55, "title": "Senior Vice President of Finance & Interim Principal Accounting Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kee-Hong  Kim Ph.D.", "age": 58, "title": "Chief Technology Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9469, "open": 0.959, "dayLow": 0.94, "dayHigh": 1.16, "regularMarketPreviousClose": 0.9469, "regularMarketOpen": 0.959, "regularMarketDayLow": 0.94, "regularMarketDayHigh": 1.16, "payoutRatio": 0.0, "beta": 3.015, "forwardPE": -0.9354838, "volume": 8551569, "regularMarketVolume": 8551569, "averageVolume": 2565103, "averageVolume10days": 2907380, "averageDailyVolume10Day": 2907380, "bid": 0.791, "ask": 1.23, "bidSize": 2, "askSize": 2, "marketCap": 189052160, "fiftyTwoWeekLow": 0.36, "fiftyTwoWeekHigh": 4.01, "fiftyDayAverage": 0.7029, "twoHundredDayAverage": 1.120535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 129595280, "profitMargins": 0.0, "floatShares": 103227433, "sharesOutstanding": 162976000, "sharesShort": 10608109, "sharesShortPriorMonth": 10701366, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0651, "heldPercentInsiders": 0.00717, "heldPercentInstitutions": 0.22174999, "shortRatio": 4.68, "shortPercentOfFloat": 0.17879999, "impliedSharesOutstanding": 162976000, "bookValue": 0.613, "priceToBook": 1.8923328, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -99617000, "trailingEps": -0.94, "forwardEps": -1.24, "enterpriseToEbitda": -1.378, "52WeekChange": -0.6067797, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 1.16, "targetHighPrice": 40.0, "targetLowPrice": 3.0, "targetMeanPrice": 10.14286, "targetMedianPrice": 5.0, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 71667000, "totalCashPerShare": 0.44, "ebitda": -94048000, "totalDebt": 12210000, "quickRatio": 5.664, "currentRatio": 5.996, "debtToEquity": 12.231, "returnOnAssets": -0.45115003, "returnOnEquity": -0.85206, "freeCashflow": -43319376, "operatingCashflow": -76949000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TNYA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tenaya Therapeutics, Inc.", "longName": "Tenaya Therapeutics, Inc.", "corporateActions": [], "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 0.00862212, "postMarketPrice": 1.1601, "postMarketChange": 0.000100017, "regularMarketChange": 0.2131, "regularMarketDayRange": "0.94 - 1.16", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2565103, "fiftyTwoWeekLowChange": 0.79999995, "fiftyTwoWeekLowChangePercent": 2.222222, "fiftyTwoWeekRange": "0.36 - 4.01", "fiftyTwoWeekHighChange": -2.8500004, "fiftyTwoWeekHighChangePercent": -0.7107232, "fiftyTwoWeekChangePercent": -60.67797, "earningsTimestampStart": 1762372800, "earningsTimestampEnd": 1762372800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.94, "epsForward": -1.24, "epsCurrentYear": -0.67714, "priceEpsCurrentYear": -1.7130873, "fiftyDayAverageChange": 0.45709997, "fiftyDayAverageChangePercent": 0.65030587, "twoHundredDayAverageChange": 0.03946495, "twoHundredDayAverageChangePercent": 0.03521974, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "regularMarketChangePercent": 22.505, "regularMarketPrice": 1.16, "postMarketTime": 1755302380, "regularMarketTime": 1755288000, "exchange": "NMS", "messageBoardId": "finmb_409125654", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Tenaya Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]